(Q34566213)

English

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M B I Lobbes

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R Prevos

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M Smidt

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

V C G Tjan-Heijnen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M van Goethem

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R Schipper

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R G Beets-Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J E Wildberger

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

29 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Insights into imaging

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

163-175

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution-NonCommercial 2.0 Generic

29 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Overview of resistance to systemic therapy in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609956

7 July 2018

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Dynamic Breast Magnetic Resonance Imaging: Pretreatment Prediction of Tumor Response to Neoadjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Why Do Purely Intraductal Cancers Enhance on Breast MR Images?

1 reference

https://api.crossref.org/works/10.1007%2FS13244-013-0219-Y

21 January 2018

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23359240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13244-013-0219-Y

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34566213&oldid=2196797293"